Archive

How once-promising Black upward mobility reversed course, and what can be done about it

The study seeks to explain why the instruments of central banking inevitably break down over time.

Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019

The success of projects for pandemic preparedness and response depends on the strength of government-business collaborations.

To fulfill MLK’s vision of jobs and freedom for Black Americans, Washington must rein in corporate greed

In this introduction to our project, “Fifty Years After: Black Employment in the United States Under the Equal Employment Opportunity Commission,” we outline the socioeconomic forces behind the promising rise and disastrous fall of an African American blue-collar middle class.

This paper considers the relationship between profits realized from higher insulin list prices, pharmaceutical innovation, and the financial structures of the three dominant insulin manufacturing companies, which set list prices.

The links between campaign contributions from the financial sector and switches to a pro-bank vote were direct and substantial

Private equity firms have become major players in the healthcare industry. How has this happened and what are the results?

Using tools from computational linguistics, we construct new measures of the impact of Brexit on listed firms in the United States and around the world

We adapt simple tools from computational linguistics to construct a new measure of political risk faced by individual US firms: the share of their quarterly earnings conference calls that they devote to political risks.

Price gouging in the US pharmaceutical drug industry goes back more than three decades.

Conventional wisdom has it that the primary function of the stock market is to raise cash for companies for the purpose of investing in productive capabilities. The conventional wisdom is wrong.

Report to the Institute for New Economic Thinking on the statistical measurement and policy implications of the compensation of the highest- paid U.S. corporate executives

Using a unique dataset provided by the Center for Responsive Politics (CRP), we document a direct channel through which financial institutions contribute to the net worth of members of the U.S. Congress, particularly those sitting on the finance committees in the Senate and the House of Representatives.